733036-95-8

Upstream product

• 242464-07-9 (Z)-7-[(1R,2R,3R,5S)-2-((E)-3-Fluoro-4-phenoxy-but-1-enyl)-5-hydroxy-3-(tetrahydro-pyran-2-yloxy)-cyclopentyl]-hept-5-enoic acid 
• 51705-18-1 [3aR,4R(1E,3S),5R,6aS]-5-benzoyloxy-4-(3-hydroxy-4-phenoxy-1-buten-1-yl)-hexahydro-2H-cyclopenta[b]furan-2-one 
• 242464-06-8 [3aR,4R(1E,3RS),5R,6aS]-4-(3-fluoro-4-phenoxy-1-buten-1-yl)-5-(tetrahydropyran-2-yloxy)-hexahydro-2H-cyclopenta[b]furan-2-one 
• 242488-25-1 [3aR,4R(1E,3RS),5R,6aS]-4-(3-fluoro-4-phenoxy-1-buten-1-yl)-5-(tetrahydropyran-2-yloxy)-hexahydro-2H-cyclopenta[b]furan-2-ol 
• 242464-05-7 [3aR,4R(1E,3RS),5R,6aS]-4-(3-fluoro-4-phenoxy-1-buten-1-yl)-5-hydroxy-hexahydro-2H-cyclopenta[b]furan-2-one 
• 51638-91-6 (3aR,4R,5R,6aS)-2-oxo-4-((E)-3-oxo-4-phenoxybut-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-5-yl benzoate 
• 242464-10-4 (5Z,13E)-(9S,11R,15RS)-15-fluoro-9-hydroxy-16-phenoxy-11-(tetrahydropyran-2-yloxy)-17,18,19,20-tetranor-5,13-prostadienoic acid isopropyl ester 

Relevant academic research and scientific papers

15-Fluoro prostaglandin FP agonists: A new class of topical ocular hypotensives

A novel series of 15-fluoro prostaglandins with phenoxy termination of the ω-chain was synthesized and evaluated for binding and functional activation of the prostaglandin FP receptor in vitro and for side effect potential and topical ocular hypotensive e